Health services deal volumes through November 15 declined by 9 percent from 2023 levels but continued to show resilience from peak volumes of 2022. Regulatory scrutiny remains top of mind for dealmakers and a level of valuation misalignment continues between buyers and sellers. However, health services deals continue to get done. PwC expects that the significant amount of available corporate and private equity capital, the prospect of further interest rate cuts and lengthening hold periods for which there is a need to realize a return on investment will all continue to accelerate deal activity into and throughout 2025.
Read the full article: PwC: Health Services – US Deals 2025 Outlook //
Source: https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html